<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2005</study_start_year><condition>Rectal Neoplasms</condition><condition>Colon Cancer</condition><condition>Rectal Cancer</condition><condition>Colonic Neoplasms</condition><disease>Rectal Neoplasms</disease><disease>Colon Cancer</disease><disease>Rectal Cancer</disease><disease>Colonic Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2022183</full_dataset_link><location>Romania</location><location>Poland</location><location>United Kingdom</location><location>Serbia</location><location>India</location><study_start_month>5</study_start_month><keyword>Leucovorin</keyword><keyword>Fluorouracil</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Clinical Trial in Patients With Metastatic Colorectal Cancer</name><description>The objective of this trial is to compare efficacy and safety of CoFactor and 5-fluorouracil (5-FU) versus leucovorin and 5-FU in treatment of metastatic colorectal cancer.</description><dates><creation>2005-05-15</creation></dates><accession>2022183</accession><cross_references><ClinicalTrials___gov>NCT00235898</ClinicalTrials___gov></cross_references></HashMap>